Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 10% phenylephrine gel for IPAA-related faecal incontinence
2006-002739-25Phase 3Completed
- Sponsor
- SLA Pharma
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fecal incontinence (FI) comparing 10% phenylephrine gel with Placebo gel (2 arms). Primary endpoint: Change in St Mark’s faecal incontinence score from baseline to end of study. Started Feb 2012; status: completed.
02
Drugs
phenylephrine
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on 2006-002739-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002739-25.